Abstracts

Browse and Search abstracts from
PPXRD-2 - PPXRD-14

Presentations

Top 21 Downloads

PPXRD-14 - NEW!

PPXRD-13

PPXRD-12

PPXRD-11

PPXRD-10

PPXRD-9

PPXRD-8

india
Learn about PPXRD-15 - 18-20 August 2017, Hyderabad, India

TOP 21 PPXRD Presentations (by Popular Download)

  1. Regulatory Considerations of Pharmaceutical Solids: Polymorphs and Co-Crystals
    Andre S. Raw, FDA, Rockville, Maryland, USA

  2. Basics of Amorphous and Amorphous Solid Dispersions
    Ann Newman, Seventh Street Development Group, Lafayette, IN

  3. Particle Size Analysis by Two-dimensional XRD
    Bob He, Bruker AXS, Inc., Madison, WI

  4. Amorphous Materials: A Structural Perspective
    Simon Bates, Triclinic Labs Inc., West Lafayette, IN, USA

  5. Using Thermal Techniques for Amorphous Materials
    Ann Newman, Seventh Street Development Group, Lafayette, IN, USA

  6. An Overview of Solid Form Screening During Drug Development
    Ann Newman, Seventh Street Development Group, Lafayette, IN

  7. New Techniques for TEM - Nanoanalysis Precession Electron Diffraction for Organic – Inorganic Nanostructures
    Stavros Nikolopoulos, NanoMEGAS SPRL, Brussels, Belgium

  8. Making Amorphous API
    Ann Newman, Seventh Street Development Group, Lafayette, IN

  9. Amorphous Solid Forms: The Use of X-ray Powder Diffraction (XRPD)
    Simon Bates, Aptuit Consulting, West Lafayette, IN

  10. Diffraction, Non-Crystallinity, and the PDF Database
    Cyrus E. Crowder, ICDD, Tim Fawcett, ICDD, Newtown Square, PA

  11. Characterisation and Prediction of Stability of Amorphous Materials During Pharmaceutical Development: Pair-wise Distribution Function
    Helen Blade, AstraZeneca, Macclesfield, Cheshire, U.K.

  12. Patenting Crystalline Forms of Pharmaceuticals: Using Solid State Science to Claim Form & Substance
    Jeffrey A. Lindeman, Ph.D., Esq., J.A. Lindeman & Co. PLLC, McLean, VA

  13. Amorphous Solids
    Lian Yu, University of Wisconsin, Madison, WI

  14. VÅNTEC-500 Area Detector for Pharmaceutical XRD
    Bob B. He, Bruker AXS, Inc., Madison, WI

  15. Total Scattering Pair Distribution Functions (TSPDF) for Fingerprinting Amorphous Pharmaceuticals
    Simon Billinge, Columbia University, New York, NY

  16. Geometry, Polarization and Absorption Corrections for Two-dimensional X-ray Diffraction
    Bob B. He, Bruker AXS, Inc., Madison, WI

  17. Your Synchrotron Powder Diffraction Instrument: 11-BM at Argonne's Advanced Photon Source
    Brian H. Toby, APS, Argonne National Laboratory, Argonne, IL

  18. Physical Stability of Amorphous Solid Dispersions: Computational Studies of 'Miscibility'
    Igor Ivanisevic, SSCI, a division of APTUIT Inc., West Lafayette, IN

  19. Reference Materials for the Study of Polymorphism and Crystallinity of Cellulose
    Tim Fawcett, ICDD, Newtown Square, PA

  20. Effect of Processing Conditions on the Physical State of Solutes in Lyophilized Formulations
    Prakash Sundaramurthi, Teva Pharmaceuticals, New York, NY

  21. Effective Use of the Powder Diffraction File
    Tim Fawcett, Cyrus Crowder, Fangling Needham, ICDD, Newtown Square, PA

PPXRD-13

PPXRD-13

PPXRD-13

 

 

 

 

 

 

 

 

PPXRD-8 - 4-7 May 2009
Glasgow, Scotland, U.K
more info

Advances in Crystal Structure Solution by EXPO2008

Angela Altomare, IC-CNR, Bari, Italy

Many Patterns and Many Methods: New Methods Utilising Multiple Analysis Techniques in Polymorph and Salt Screening Systems

Gordon Barr, University of Glasgow, Glasgow, Scotland, U.K.

Characterisation and Prediction of Stability of Amorphous Materials During Pharmaceutical Development: Pair-wise Distribution Function

Helen Blade, AstraZeneca, Macclesfield, Cheshire, U.K.

Crystallite Sizes and Microstrains Determined by Rietveld Refinement: Application to Milled Lactose

Vincent Caron, Trinity College Dublin, Dublin, Ireland

Diffraction, Non-Crystallinity, and The PDF Database

Cyrus Crowder, ICDD, Newtown Square, PA, U.S.A.

Material Identification: The Descriptive Statistics of Phase Identification

Timothy Fawcett, ICDD, Newtown Square, PA, U.S.A.

New Possibilities for X-ray Diffractometry

Bernd Hasse, Incoatec GmbH, Geesthacht, Germany

Environmental Atomic Force and Confocal Raman Microscopies in Pharmaceutical Science

Greg Haugstad, University of Minnesota, Minneapolis, MN, U.S.A.

Particle Size Analysis by Two-Dimensional XRD

Bob He, Bruker-AXS, Inc., Madison, WI, U.S.A.

Physical Stability of Amorphouse Solid Dispersions: XRPD and Computational Studies of 'Miscibility'

Igor Ivanisevic, SSCI, a division of APTUIT Inc., West Lafayette, IN, U.S.A.

ROUND ROBIN for PHARMACEUTICAL COMPOUNDS

ROUND ROBIN for PHARMACEUTICAL COMPOUNDS - RESULTS ANALYSIS AND CLUSTER ANALYSIS

Fangling Needham, Cyrus Crowder, Timothy Fawcett, ICDD, Newtown Square, PA, U.S.A.

Application of X-ray Spectrometry at X-ray Absorption Edges for Investigation of Human Albumin

Konstantin Pogrebitsky, Ioffe Physical-Technical Institute, Saint-Petersburg, Russia

Computed Crystal Energy Landscatpes as an Aid to Understanding Polymorphism

Sarah (Sally) L. Price, University College London, London, U.K.

Power Diffractoin and Crystal Structure Prediction: A Two-Way Relationship

Maryjane Tremayne, University of Birmingham, Birmingham, U.K.

Quantitative Analysis of Phases with Parial or No Known Crystal Structure

Geert Vanhoyland, Bruker AXS GmbH, Karlsruhe, Germany

Protein Powder Diffraction at the ESRF

Jonathan Wright, ESRF, Grenoble cedex, France

Studying Amorphous Pharmaceutical Materials by Powder X-ray Diffraction and Other Solid-State Techniques

Shawn Yin, Birstol-Myers Squibb, New Brunswick, NJ, U.S.A.

 

PPXRD-9 - 22–25 February 2010
Hilton Head Island, South Carolina, U.S.A.
more info

Invited - The Amorphous State: A Structural Perspective

Simon Bates
Aptuit Consulting, West Lafayette, IN

The Use of Field-Portable pXRD for the Rapid Identification of Counterfeit Pharmaceutical Products and Subsequent Excipient Identification and Quantification- PRESENTATION

David Blake
NASA Ames Research Center, Moffett Field, CA

X-ray Powder Diffraction Database Tools for the Pharmaceutical Scientist: New Capabilities

Cyrus E. Crowder
International Centre for Diffraction Data, Newtown Square, PA

PXRD with Raman Spectroscopy, DSC and IR DATA

Chris Gilmore
University of Glasgow, Glasgow, UK

Geometry, Polarization and Absorption Corrections for Two-Dimensional XRD

Bob B. He
Bruker AXS, Inc., Madison, WI

PXRD Investigation of Changes in Dehydration Behavior of 7-Methoxy-1-Methyl-5-(4-(Trifluoromethyl)Phenyl)-[1,2,4]Triazolo[4,3-A]Quinolin-4-Amine Hydrate After Micronization

Feirong Kang
GlaxoSmithKline, King of Prussia, PA

Invited - Patenting Crystalline Forms of Pharmaceuticals – Using Solid State Science to Claim Form & Substance

Jeffrey A. Lindeman
J.A. Lindeman & Co. PLLC, McLean, VA

Polymorphs in PDF-4/Organics 2010

Fangling Needham
International Centre for Diffraction Data, Newtown Square, PA

Amorphous Basics

Ann Newman
Seventh Street Development Group, Lafayette, IN

Invited - Drug Product Characterization: What Form Do I Have?

Ann Newman
Seventh Street Development Group, Lafayette, IN

Ab Initio Crystal Structure Determination of Two Polymorphic Modifications of an Anesthetic Agent, Tetracaine Hydrochloride, Using a Combination of Molecular Modeling and Synchrotron X-ray Powder Diffraction Techniques

Robert Papoular
Leon Brillouin Laboratory, Gif-sur-Yvette, France

Invited - Structure Studies of Disordered Pharmaceutical Materials by High-Energy X-ray Diffraction and Atomic Pair Distribution Function Analysis

Valeri Petkov
Central Michigan University, Mt. Pleasant, MI

Easy Access to Synchrotron Powder Diffraction on Pharmaceuticals

Brian H. Toby
APS, Argonne National Laboratory, Argonne, IL

 

PPXRD-10 - 16-19 May 2011
Lyon, France
more info

Using XRD to monitor the influence of milling on physical properties of a hydrate

Itai Adin, CHEMAGIS LTD, Israel

In situ Measurement and Characterization of Crystal Growth by X-ray Diffraction - Crystallization Monitoring - a QbD tool

Detlef Beckers, PANalytical B.V., Almelo, The Netherlands

Stability and Desolvation Kinetics of Droperidol Hydrates and an Ethonal Solvate, Studied by Powder X-ray Diffraction and Differental Thermal Analysis/Termogravimetry

Agris Berzins, University of Latvia, RÓga, Latvia

Total Scattering Pair Distribution Functions (TSPDF) for Fingerprinting Amorphous Pharmaceuticals

Simon Billinge, Columbia University, New York, NY, USA

A Novel Method to Determine Amorphous Phase Concentrations Using the Rietveld Refinement Technique

Xim Bokhimi, Instituto de FÌsica, Universidad Nacional AutÛnoma de

Addressing the challenges in applying crystal structure prediction to pharmaceutical materials

Graeme M. Day, Department of Chemistry, University of Cambridge, Cambridge,

Reference Materials for the Study of Polymorphism and Crystallinity of Cellulose

Tim Fawcett, ICDD, Newtown Square, PA, USA

Application of Automated Electron Diffraction to Structural Investigation of Molecular Crystals

Tatiana Gorelik, Johannes-Gutenberg University Mainz, Mainz, Germany

VÅNTEC-500 Area Detector for Pharmaceutical XRD

Bob He, Bruker AXS Inc, Madison, WI, USA

Investigation of Solid-state Stability of a Co-crystal API in Formulation Development by XRPD and ss- NMR Spectroscopy

Z. Jane Li, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA

An Overview of Solid Form Screening During Drug Development

Ann Newman, Seventh Street Development Group, Lafayette, IN, USA

NEW techniques for TEM - nanoanalysis  precession electron diffraction for organic  –  inorganic nanostructures

Stavros Nikolopoulos, NanoMEGAS SPRL, Brussels, Belgium

HR-XRPD and Polymorph Stability

Ivo B. Rietveld, UniversitÈ Paris Descartes, Paris, France

Complementary Crystallography and X-ray Powder Diffraction Methods

Greg Stephenson, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

Effect of Processing Conditions on the Physical State of Solutes in Lyophilized Formulations

Prakash Sundaramurthi, Scientific Affairs, Teva Parenteral Medicines. Inc., Irvine CA, USA

Polymorphism and Solvates of Flecainide Base

Kaspar Veldre, University of Latvia, RÓga, Latvia

 

PPXRD-11 - 15-18 May 2012
Sanibel Harbour Marriott Resort & Spa, Fort Myers, Florida, U.S.A.
more info

Welcoming Remarks and Introductions from the Program Chair

Cyrus E. Crowder, ICDD, Newtown Square, PA, U.S.A.

Using PXRD for Amorphous Materials

Simon Bates
Triclinic Labs Inc.,
West Lafayette, IN, USA

Desolvation of Droperidol Isostructral Solvates

A. Bērziņš, A. Actiņš, T. Rēķis, I. Sarceviča
University of Latvia, Rīga, Latvia

Solid-Form Screening and Selection: Strategies and Challenges of Difficult Molecules

Pingyun (P.Y.) Chen,* J. Bis, S. Carino, R. Couch, D. Igo, L. Katrincic, D. Kinder, B.Norton, S. Sukumar
OptiformTM Technologies, Catalent Pharma Solutions, Research Triangle Park, NC, USA

Addressing the Amorphous Content Issue in Quantitative Phase Analysis: The Cretification of NIST Standard Reference Material 676A

J. Cline*, J. J. Filliben
NIST, Gaithersburg, MD, USA
R. B. Von Dreele
Argonne National Laboratory, Argonne, IL, USA
R. Winburn
Minot State University, Minot, ND, USA
P. W. Stephens
State University of New York at Stony Brook, Stony Brook, NY, USA

Material Identification and Characterization: 10 Years of Developments, the PDF-4/Organics Database

T. G. Fawcett*, S.N. Kabbekodu, F. Needham, C. E. Crowder
International Centre for Diffraction Data, Newtown Square, PA, USA

New Instrumentation for Pharmaceutical XRD

B. He
Bruker AXS, Madison, WI, USA

Crystal Structure Prediction: Synergy Between Theory and Experiment

James A. Kaduk
Illinois Institute of Technology, Chicago IL, USA

Making Amorphous API

Ann Newman
Seventh Street Development Group, Lafayette, IN, USA

Using Thermal Techniques for Amorphous Materials

Ann Newman
Seventh Street Development Group, Lafayette, IN, USA

Regulatory Considerations of Pharmaceutical Solids: Polymorphs and Co-Crystals

Andre S. Raw
FDA, Rockville, Maryland, USA

Ultrafast Lasers for the Detection and Quantification of Trace Crystallinity in Amorphous Formulations by SONICC

Garth Simpson
Purdue University,
West Layette, IN, USA

Nucleation and the Differing Crystallization Behavior of Enantimers

Gregory A. Stephenson*, C. D. Wolfangel
Eli Lilly and Company, Indianapolis, IN, USA

SONICC AND TPE-UVF Analysis oF APIS and Common Excipients

S. Toth*, G. J. Simpson J. T. Madden, L. S. Taylor,
College of Pharmacy, Purdue University, West Lafayette, IN, USA
P. Marsac
Merck & Co., Inc., West Point, PA, USA

Molecular CoCrystals and Salts: 'Full' Structural Characterization from Powder Diffraction Data

Maryjane Tremayne*, L. Thompson, A. Cowell, G. Cutts,  D. Bell
University of Birmingham, Edgbaston, Birmingham, UK

Amorphous Quantitation Strategy for Crystalline Drug Substance - A GSK Perspective

Peter Varlashkin
Physical Properties, GSK
Durham, NC, USA

The Strategy for Quantitation of Residual Amorphous in Crystalline API

Peter Varlashkin
Physical Properties, GSK
Durham, NC, USA

Structural Characterization of Solid Composite Materials as a Tool fro Drug Product Formulation and Development

Peter Wildfong
Duquesne University, Pittsburgh, PA, USA

The Study of Mictronization Induced Disorder of Active Pharmaceutical Ingredients by XRPD Line Broadening Analyses

G. Williams*, R. Forcino, J. Brum, F. Vogt
GlaxoSmithKline, King of Prussia, PA, USA

Amorphous Basics

Lian Yu
University of Wisconsin,
Madison, WI, USA

Amorphous Organic Solids and Their Crystallization

Lian Yu
University of Wisconsin,
Madison, WI, USA

 

PPXRD-12 - 20-24 May 2013
Institute of Physics, Chinese Academy of Sciences, Beijing, China
more info

Invited - An Investigation of Non-Crystalline Materials Using X-ray Powder Diffraction

S. Bates, Triclinic Labs, West Layfayette, IN, USA

Improving the Pharmaceutical Subfile for the ICDD PDF-4/Organics Database

C.E. Crowder*, S. Pagola, T.G. Fawcett, ICDD, Newtown Square, PA, USA
M. Suchomel, L. Ribaud, B. Toby, APS, Argonne National Laboratory, Argonne, IL, USA
J.A. Kaduk, Illinois Institute of Technology, Chicago, IL, USA

Invited - Hard X-ray Free Electron Lasers for Structural Biology: Structure Determination of Nano-crystals and Single Particles

Y.H. Dong, Beijing Synchrotron Radiation Facility, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China

Best Practices in Formulation Analyses by X-ray Diffraction

T.G. Fawcett*, S.N. Kabekkodu, S.D. Gates, A.M. Gindhart, J.R. Blanton, C.E. Crowder, International Centre for Diffraction Data, Newtown Square, PA, USA

The Development of Nanomaterials and Amorphous References and their Use in Pharmaceutical Identification and Characterization

T.G. Fawcett, S.N. Kabekkodu, S.D. Gates, A.M. Gindhart, J.R. Blanton, C.E. Crowder, ICDD, Newtown Square, PA, USA

Advances in Synchrotron XRPD for the Enhanced Characterization of Pharmaceuticals

F. Gozzo*, Excelsus Structural Solutions SPRL, Brussels, Belgium
I. Madsen, CSIRO Process Science and Engineering, Victoria, Australia
B. Aresta, C. Giannini, National Research Council, Institute of Crystallography, Bari, Italy

Recent Advances in PPXRD Instrumentation and Application

B. He, Bruker AXS, Inc., Madison, WI, USA

The Determination of Amorphous Content

A. Kern, Bruker AXS, Inc., Karlsruhe, Germany

Invited - Crystal Structure Analysis of Pharmaceuticals with Electron Diffraction

 

S. Nicolopoulos*, Nanomegas, Brussels, Belgium
M. Gemmi, IIT Researcher, Pisa, Italy
F. Gozzo, Excelsus Structural Solutions SPRL, Brussels, Belgium

Mechanochemically Initiated Isoniazid–Benzoic Acid Cocrystal Formation Under Accelerated Conditions

 

I. Sarcevica, L. Orola, University of Latvia, Riga, Latvia
S. Belyakov, Latvian Institute of Organic Synthesis, Riga, Latvia

Crystal Structure Determination and Rietveld Refinement of Two Anhydrous Rifampicin Polymorphs using High-Resolution Synchrotron X-ray Powder Diffraction

 

R.C. Seiceira*, A. Pitaluga Jr, T.C. dos Santos, Institute of Drug Technology, Farmanguinhos, Fiocruz, Rio de Janeiro, Brazil
A.L. Ibiapino, A.C. Trindade, F.F. Ferreira, Federal University of ABC, Natural and Human Sciences Center, Santo André, Brazil

Hydration / Dehydration Mechanism of Pharmaceutical Crystals Revealed by SDPD Method

H. Uekusa*, K. Fujii, Tokyo Institute of Technology, Japan

Invited - Process-Induced Phase Changes and Potential Impacts on Drug Product Performance

D. Zhou, AbbVie, North Chicago, IL, USA

 

PPXRD-13 - 18-21 May 2015 
BLACK FOREST PANORAMA - Schwarzwald Panorama, Bad Herrenalb, Germany
more info

Invited - The Relationship Between Stability and X-ray Powder Diffraction Profile for Non-crystalline Solid Forms

Simon Bates*, D. Jonaitis, T. Capozzi, P. Stahly, Triclinic Labs, Lafayette, IN, USA

Study of Biological Macromolecules with a Labortory X-ray Diffraction System

Detlef Beckers*, T. Degen, G. Nénert, J. Bolze, PANalytical B.V., Almelo, The Netherlands
S. Saslis, S. Logotheti, I. Margiolaki, University of Patras, Patras, Greece
V. Kogan, Dannalab, Enschede, The Netherlands

Structural Characterization and Rationalization of Formation, Stability, and Transformations of Benperidol Solvates

Agris Bērziņš*, University of Latvia, Riga, Latvia and Durham University, Durham, UK
E. Skarbulis, A. Actinš, University of Latvia, Riga, Latvia

ICDD Powder Diffraction File® Coverage of Polymers Used in Pharmaceutical and Biomedical Applications

Tom Blanton*, S. Gates, ICDD, Newtown Square, PA, USA

Ultrafast Crystal Structure Determination of Pharmaceutical Compounds using TEM Electron Diffraction without Cooling Techniques

Partha Pratim Das*, NanoMEGAS SPRL, Brussels, Belgium & Electron Crystallography Solutions, Madrid, Spain
E. Van Genderen, J.P. Abrahams, University of Leiden, Leiden, Netherlands
S. Nicolopoulos, NanoMEGAS SPRL, Brussels, Belgium

Molecular Complexes of Agomelatine-Phosphoric Acid: Crystal Structure Determination and Phase Transformation Kinetics by Non-Ambient Powder XRD


R.S. Voguri, R.R. Chirla, Archan Dey*
, Dr. Reddy's Laboratories Limited, Hyderabad, India

Analyzing Amorphous and Nanocrystalline Materials by Full Pattern Analyses


Timothy Fawcett*, S.N. Kabekkodu, K. Zhong, A.M. Gindhart, J.R. Blanton, T.N. Blanton, ICDD, Newtown Square, PA, USA

Optimizing PDF Data Quality using a Laboratory Powder Diffractometer

Thomas Hartmann*, Stoe & Cie GmbH, Darmstadt, Germany

Expanding the Scope of PDF4/Organics in Pharmaceutical PXRD Analysis

S. Kabekkodu* T.G. Fawcett, , K. Zhong, A.M. Gindhart, S. Gates, J.R. Blanton, T.N. Blanton, ICDD, Newtown Square, PA, USA

Invited - Crystal Structures of Large-Volume Commercial Pharmaceuticals with Z'>1

James Kaduk*, Illinois Institute of Technology, Chicago, IL, USA
J.W. Reid, Canadian Light Source, Saskatoon, Canada
R. Papoular, Leon Brillouin Lab., Saclay, France
K. Zhong, A.M. Gindhart, T.N. Blanton, ICDD, Newtown Square PA, USA

The Power of Powder: Protein-based Drug Screening


Irene Margiolaki*
, University of Patras, Patras, Greece

Instrumentation for Tackling Current and Future Challenges in Pharmaceutical R&D

Dubravka Šišak Jung*, DECTRIS Ltd, Baden, Switzerland
T. Hartmann, Stoe & Cie GmbH, Darmstadt, Germany

Verification of Crystal Structures Determined from PXRD— the Role of DFT-D

Jacco van de Streek*, University of Copenhagen, Copenhagen, Denmark

PPXRD-13 Workshop - Quantitative phase analysis by XRPD

Quantitative phase analysis by XRPD
Organizers and Instructors:
Arnt Kern, Burker AXS GmbH, Germany
Detlef Beckers, PANalytical B.V., The Netherlands
Fabia Gozzo, Excelsus Structural Solutions SPRL, Belgium
Robert Dinnebier, MPI für Festkörperforschung, Germany
Arnaud Grandeury, Novartis Pharma AG

Quantification of Amorphous Phases - Theory
Robert DinnebierMax-Planck Institute für Festkoerperforschung, Stuttgart, Germany

Quantitative Phase Analysis with Diffraction Methods
Fabia Gozzo*, Excelsus Structural Solutions SPRL, Brussels, Belgium

QPA instrumentation, sample and validation aspects
Detlef Beckers, PANalytical B.V., The Netherlands

Quantification of traces - pushing the limits with laboratory instrumentation
Detlef Beckers, PANalytical B.V., The Netherlands

 

 

PPXRD-14 -6-9 June 2016  
Sanibel Harbour Marriott, Fort Myers, Florida, U.S.A.
more info

Invited – Using X-ray Powder Diffraction and Other Solid-State Data to Protect Pharmaceutical Inventions
E.H. Barash*, Barash Law LLC, Lafayette, IN, USA
Humidity Induced Phase Transitions in HEWLYSOZYME Investigated By Microcrystalline Powder Diffraction
D. Beckers*, T. Degen, G. Nénert, PANalytical B.V., Almelo, The Netherlands
S. Saslis, S. Logotheti, F. Karavassili, A. Valmas, I. Margiolaki, University of Patras, Greece
S. Trampari, Kapodistrian University of Athens, Greece
Excipient Reference Data in the Powder Diffraction File™ (PDF®) for Phase Identification in Pharmaceutical Formulations
J. Quagliarello, K. Krishnan, S. Gates-Rector, T.G. Fawcett, T.N. Blanton*, International Centre for Diffraction Data, Newtown Square, PA, USA
ICDD Powder Diffraction File Coverage of Polymers Used in Pharmaceutical and Biomedical Applications
T.N. Blanton, International Centre for Diffraction Data, Newtown Square, PA, USA
Crystal Structure Determination from Beam Sensitive Organic Materials using Electron Diffraction
P.P. Das*, S. Nikolopoulos, NanoMEGAS SPRL, Brussels, Belgium
Invited - Instrumentation and Applications of 2D XRD for Pharmaceutics
B.B. He*, Bruker AXS, Madison, WI, USA
The Analysis of Non-Crystalline Materials in Pharmaceutical Formulations
T.G. Fawcett*, S.N. Kabekkodu, S. Gates-Rector, A.M. Gindhart, J.R. Blanton, T.N. Blanton, International Centre for Diffraction Data, Newtown Square, PA, USA
Large-Area CdTe Pixel Detectors for High-Energy X-ray Diffraction Applications
D. Sisak Jung*, T. Donath, DECTRIS Ltd., Switzerland
J. Bednarcik, Deutsches Elektronen-Synchrotron, Germany
M. Di Michiel, European Synchrotron Radiation Facility, France
S. Jacques, School of Materials, University of Manchester, UK
Absolute Quantification of Pharmaceuticals: The Search of Suitable Internal Standards
M.L. Reinle-Schmitt*, Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland
P.P. Mazzeo, Excelsus Structural Solutions (Swiss) AG, Switzerland
A. Prodi, Excelsus Structural Solutions SPRL, Belgium
F. Gozzo , Excelsus Structural Solutions (Swiss) AG, Switzerland and Excelsus Structural Solutions SPRL, Belgium
Invited – Strategies to Expand Solid-state Landscapes of Drugs to Enable Successful Tablet Formulation Development
C. Sun*, Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA
Invited - Two-Dimensional X-ray Diffractometry in Pharmaceutical Product and Process Development
N.K. Thakral*, Amgen Inc., Thousand Oaks, CA, USA
Invited – Capturing the Significance of X-ray Crystallography in Pharmaceutical Field: The Application to Characterize New Salt, Co-Crystal and Co-Amorphous
E. Yonemochi*, Hoshi University, Tokyo, Japan

PPXRD-14 Workshop - Quantitative phase analysis by XRPD

Quantitative Phase Analysis by XRPD
Organizer & Instructors: A. Kern, Bruker AXS GmbH, Karlsruhe, Germany, arnt.kern@bruker.com
F. Gozzo, Excelsus Structural Solutions SPRL, Brussels, Belgium, fabia.gozzo@excels.us
M. Reinle-Schmitt, Paul Scherrer Institut, Swiss Light Source, Villigen, Switzerland, mathilde.reinle-schmitt@psi.ch

QPA of crystalline and amorphous phase abundance with XRPD techniques: bases and methods
F. Gozzo

Synchrotron XRPD
F. Gozzo

Practical assessment of merits of methods for QPA
A. Kern

Issues in QPA - minimising systematic errors
A. Kern

Challenges of absolute quantification of pharmaceuticals by the internal standard methods
M. Reinle-Schmitt

Instrumentation and sample presentation
A. Kern
F. Gozzo